Combined arteriovenous sheathotomy and intraoperative intravitreal triamcinolone acetonide for branch retinal vein occlusion.
OBJECTIVE
To describe the treatment of macular oedema secondary to branch retinal vein occlusion (BRVO) with concomitant pars plana vitrectomy/arteriovenous sheathotomy and intraoperative intravitreal triamcinolone acetonide.


METHODS
Retrospective case series.


RESULTS
Four eyes of four patients were identified. Patients improved from a mean best-corrected visual acuity of 20/124 at baseline to 20/122 at month 1, 20/83 at month 3, 20/74 at month 6, 20/59 at month 9 and 20/44 at month 12 (p = 0.01). All patients demonstrated improvement in visual acuity and macular oedema on fluorescein angiography and/or optical coherence tomography (OCT).


CONCLUSIONS
For patients with persistent macular oedema due to BRVO refractory to pharmacotherapy and/or laser photocoagulation, concomitant pars plana vitrectomy with arteriovenous sheathotomy and intravitreal triamcinolone may improve best-corrected acuity and reduce macular oedema on fluorescein angiography and OCT.
Hwang
John C
JC
Edward S Harkness Eye Institute, Columbia University Medical Center, New York, NY 10032, USA. sc433@columbia.edu
Gelman
Susan K
SK
Fine
Howard F
HF
Chang
Stanley
S
Del Priore
Lucian V
LV
D000283:Administration, Intravesical; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D008269:Macular Edema / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012170:Retinal Vein Occlusion / Q000628:therapy*; D012189:Retrospective Studies; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014792:Visual Acuity; D014821:Vitrectomy / Q000379:methods*
D000893:Anti-Inflammatory Agents; D014222:Triamcinolone Acetonide